Assisted Reproductive Technology Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Infertility rates
   3. Market Restraints
      1. High Cost of Treatment
      2. Legal & Ethical Challenges
   4. Market Opportunity
      1. Growing Awareness and Acceptance
   5. Market Trends
      1. Expansion of Fertility Preservation Services
      2. Growth in Cross-Border Reproductive Care (CBRC)
5. MARKET SEGMENTATION
   1. By Technology
      1. In-Vitro Fertilization
      2. Artificial Insemination
      3. Surrogacy
   2. By Procedure
      1. Frozen Donor
      2. Frozen Non Donor
      3. Fresh Donor
      4. Fresh Non Donor
      5. Embryo Banking
   3. By Application
      1. Fertility Clinics
      2. Hospitals
      3. Others
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Anecova (Switzerland)
      2. Bloom Fertility Centre (India)
      3. California Cryobank (U.S.)
      4. Celmatix Inc. (U.S.)
      5. CooperSurgical (U.S.)
      6. Esco Micro Pte Ltd. (Singapore)
      7. Ferring B.V. (Switzerland)
      8. FUJIFILM Irvine Scientific (U.S.)
      9. Genea Limited (Australia)
      10. ICU Medical, Inc. (U.S.)
      11. INVO Bioscience (U.S.)
      12. Laboratoire CCD (France)
      13. Merck KGaA (Germany)
      14. Nidacon International AB (Sweden)
      15. Nikon Instruments Inc. (U.S.)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Assisted Reproductive Technology market?

The global market of assisted reproductive technologyis projected to reach USD 61.45 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Assisted Reproductive Technology market?

The global assisted reproductive technologymarket has an estimated annual growth rate of 8.1%.

Q.3. What are the recent trends of Assisted Reproductive Technology market?

Expansion of fertility preservation services and growth in Cross-Border Reproductive Care (CBRC)are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Assisted Reproductive Technology?

The major companies profiled in this report include Anecova (Switzerland), Bloom Fertility Centre (India), California Cryobank (U.S.), Celmatix Inc. (U.S.), CooperSurgical (U.S.), Esco Micro Pte Ltd. (Singapore), Ferring B.V. (Switzerland), FUJIFILM Irvine Scientific (U.S.), Genea Limited (Australia), ICU Medical, Inc. (U.S.), INVO Bioscience (U.S.), Laboratoire CCD (France), Merck KGaA (Germany), Nidacon International AB (Sweden), Nikon Instruments Inc. (U.S.), among others.  

Q.5. Which is the largest regional market in the Assisted Reproductive Technology?

North America is the largest regional market for assisted reproductive technology.